LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Brito, Fernanda Carla Ferreira de"
  2. AU="Olgac, Ufuk"
  3. AU="Guo, Jinping"
  4. AU="Mayhew, Nicholas J"

Search results

Result 1 - 4 of total 4

Search options

  1. Article: Reviewing Atrial Fibrillation Pathophysiology from a Network Medicine Perspective: The Relevance of Structural Remodeling, Inflammation, and the Immune System.

    Martins, Ivis Levy Fernandes / Almeida, Flávia Valéria Dos Santos / Souza, Karyne Pollo de / Brito, Fernanda Carla Ferreira de / Rodrigues, Gabriel Dias / Scaramello, Christianne Bretas Vieira

    Life (Basel, Switzerland)

    2023  Volume 13, Issue 6

    Abstract: Atrial fibrillation (AF) is the most common type of sustained arrhythmia. The numerous gaps concerning the knowledge of its mechanism make improving clinical management difficult. As omics technologies allow more comprehensive insight into biology and ... ...

    Abstract Atrial fibrillation (AF) is the most common type of sustained arrhythmia. The numerous gaps concerning the knowledge of its mechanism make improving clinical management difficult. As omics technologies allow more comprehensive insight into biology and disease at a molecular level, bioinformatics encompasses valuable tools for studying systems biology, as well as combining and modeling multi-omics data and networks. Network medicine is a subarea of network biology where disease traits are considered perturbations within the interactome. With this approach, potential disease drivers can be revealed, and the effect of drugs, novel or repurposed, used alone or in combination, may be studied. Thus, this work aims to review AF pathology from a network medicine perspective, helping researchers to comprehend the disease more deeply. Essential concepts involved in network medicine are highlighted, and specific research applying network medicine to study AF is discussed. Additionally, data integration through literature mining and bioinformatics tools, with network building, is exemplified. Together, all of the data show the substantial role of structural remodeling, the immune system, and inflammation in this disease etiology. Despite this, there are still gaps to be filled about AF.
    Language English
    Publishing date 2023-06-10
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662250-6
    ISSN 2075-1729
    ISSN 2075-1729
    DOI 10.3390/life13061364
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Challenges in Pharmacological Management of Cardiovascular Diseases in Covid-19

    Pedro, Samuel de Sousa / Brito, Fernanda Carla Ferreira de / Scaramello, Christianne Bretas Vieira

    International Journal of Cardiovascular Sciences v.33 n.4 2020

    do Benefits Outweigh Risks?

    2020  

    Keywords Cardiovascular Diseases/mortality ; Coronavirus/complications ; COVID-19/complications ; Pandemics ; SARS Severe Acute Respiratory Syndrome ; Dyspnea ; Fever ; Anticoagulants ; covid19
    Language English
    Publishing date 2020-07-01
    Publisher Sociedade Brasileira de Cardiologia
    Publishing country br
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article: Challenges in Pharmacological Management of Cardiovascular Diseases in Covid-19: do Benefits Outweigh Risks?

    Pedro, Samuel de Sousa / Brito, Fernanda Carla Ferreira de / Scaramello, Christianne Bretas Vieira

    International Journal of Cardiovascular Sciences

    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #819651
    Database COVID19

    Kategorien

  4. Article ; Online: Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target.

    Motta, Nadia Alice Vieira / Autran, Lis Jappour / Brazão, Stephani Correia / Lopes, Rosane de Oliveira / Scaramello, Christianne Brêtas Vieira / Lima, Gabriel Ferreira / Brito, Fernanda Carla Ferreira de

    International immunopharmacology

    2020  Volume 92, Page(s) 107336

    Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19) that has emerged and rapidly spread across the world. The COVID-19 severity is associated to viral pneumonia with additional extrapulmonary ... ...

    Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19) that has emerged and rapidly spread across the world. The COVID-19 severity is associated to viral pneumonia with additional extrapulmonary complications. Hyperinflammation, dysfunctional immune response and hypercoagulability state are associated to poor prognosis. Therefore, the repositioning of multi-target drugs to control the hyperinflammation represents an important challenge for the scientific community. Cilostazol, a selective phosphodiesterase type-3 inhibitor (PDE-3), is an antiplatelet and vasodilator drug, that presents a range of pleiotropic effects, such as antiapoptotic, anti-inflammatory, antioxidant, and cardioprotective activities. Cilostazol also can inhibit the adenosine uptake, which enhances intracellular cAMP levels. In the lungs, elevated cAMP promotes anti-fibrotic, vasodilator, antiproliferative effects, as well as mitigating inflammatory events. Interestingly, a recent study evaluated antiplatelet FDA-approved drugs through molecular docking-based virtual screening on viral target proteins. This study revealed that cilostazol is a promising drug against COVID-19 by inhibiting both main protease (M
    MeSH term(s) Cilostazol/therapeutic use ; Humans ; Phosphodiesterase 3 Inhibitors/therapeutic use ; SARS-CoV-2 ; COVID-19 Drug Treatment
    Chemical Substances Phosphodiesterase 3 Inhibitors ; Cilostazol (N7Z035406B)
    Language English
    Publishing date 2020-12-28
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 2043785-7
    ISSN 1878-1705 ; 1567-5769
    ISSN (online) 1878-1705
    ISSN 1567-5769
    DOI 10.1016/j.intimp.2020.107336
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top